Boston, MA · Founded 2022 · Privately Held (backing)
Operator of a biologics platform intended to enable targeted cancer treatment using tumor-specific biochemical markers. Crosslink Therapeutics is based in Boston, MA and was founded in 2022. It has raised $8 million across 1 recorded round; the latest was a $4.3 million seed round in Apr 2025.
Last price · $/share
—
Implied valuation
—
Total raised
$8.0M
Last round
Seed Round
Apr 2025
Cap table — not yet on record
Crosslink Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Crosslink Therapeutics with a free account
·Watch Crosslink Therapeutics: the Monday email on marks, rounds and moves
Where does Crosslink Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Crosslink Therapeutics's 1 recorded funding rounds.